Predicción del comportamiento de marcadores cardíacos por inteligencia artificial en pacientes hipertensos y diabéticos con síndrome coronario agudo
DOI:
https://doi.org/10.22529/me.2022.7(2)06Parole chiave:
sensibilidad, red neuronal, biomarcadores, enfermedad cardíaca, predicciónAbstract
INTRODUCCIÓN: Estudios recientes han demostrado que la sensibilidad de los marcadores cardíacos troponinas y creatina quinasa depende de otras condiciones que presenten pacientes diabéticos e hipertensoscon síndrome coronario agudo.OBJETIVO: Utilizar un modelo predictivo del comportamiento de los marcadores cardíacos.MATERIAL Y MÉTODO: se realizó un estudio descriptivo, aleatorio, retrospectivo y observacional en pacientes con diabetes (n = 76) e hipertensión (n = 22) con síndrome coronario agudo.RESULTADOS: la red de percepton mostró que n = 10, 12 y 10 (100%) de los pacientes con diabetes, Creatina Quinasa (CK-MB) (0,8 y 12 hs) mostró una predicción de valores ≤ 25 UI / L. Troponina (cTnI) n = 7 (77,8%), n = 7 (77,8%) y n = 5 (62,5%) de los pacientes en el grupo de prueba (0, 8 y 12 hs) se observó una predicción de niveles ≤ 0,01 ng / ml. En los pacientes hipertensos los resultados obtenidos fue que n = 6, 5 y 5 (100%) de los pacientes CK-MB (0, 8 y 12 hs) mostró una predicción de una actividad ≤25 UI / L. cTnI mostró que n = 2 (50.0%), n = 2 (66.7%) y n = 3 (75.0%) de los pacientes (0, 8 y 12 hs) mostró una predicción de niveles ≤ 0,01 ng / ml.CONCLUSIONES: la sensibilidad y los valores plasmáticos de los marcadores cardíacos, se modifican al momento del diagnóstico de la enfermedad cardíaca en pacientes diabéticos e hipertensos.Downloads
Riferimenti bibliografici
Wang, J, Tan, GJ, Han, LN, et al. Novel biomarkers for cardiovascular risk prediction. J Geriatr Cardiol 2017;14 (2):135-150.
Zagidullin, N, Motloch, LJ, Gareeva, D, et al. Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction. J Clin Med 2020;9 (2): https://doi.org/10.3390/jcm9020550
Banerjee, D, Perrett, C, Banerjee, A. Troponins, Acute Coronary Syndrome and Renal Disease: From Acute Kidney Injury Through End-stage Kidney Disease. Eur Cardiol 2019;14 (3):187- 190. https://doi.org/10.15420/ecr.2019.28.2
Amin, EA. ACEI Relation with Cardiac Enzyme CK-MB Levels in Hypertensive Patients. Iraqi J Comm Med 2009;22 (4):
Joison A, Baiardi G. Effect of Pharmacological treatment on cardiac biomarkers in patients with acute coronary syndrome of non-ST segment elevation with Type-2 diabetes International Journal of Medical and Health Sciences 2016;5 (1):32-37.
Joison A, Barcudi R, Baiardi G. Modification of cardiac biomarkers sensitivity in hypertensive patients treated with angiotensin-converting enzyme inhibitors in acute coronary syndrome with non-st segment elevation Journal of International Research in Medical andPharmaceutical Sciences 2019;4 (2):39-46.
Isma'eel, HA, Cremer, PC, Khalaf, S, et al. Artificial neural network modeling enhances risk stratification and can reduce downstream testing for patients with suspected acute coronary syndromes, negative cardiac biomarkers, and normal ECGs. Int J Cardiovasc Imaging 2016;32 (4):687- 696. https://doi.org/10.1007/s10554-015-0821-9
Mehta, N, Pandit, A, Shukla, S. Transforming Healthcare with Big Data Analytics and Artificial Intelligence: A Systematic Mapping Study. J Biomed Inform 2019;17 (103311):103311. https://doi.org/10.1016/j.jbi.2019.103311
Prabhakaran, D, Ajay, VS, Tandon, N. Strategic Opportunities for Leveraging Low-cost, High-impact Technological Innovations to Promote Cardiovascular Health in India. Ethn Dis 2019;29 (Suppl 1):145-152. https://doi.org/10.18865/ed.29.S1.145
Sprockel J, DJ, Alzatec W, González E. Networks neural in he diagnosis of the heart attack acute of myocardium. Revista Colombiana de Cardiología 2013;21 (4):215-223. https://doi.org/10.1016/j.rccar.2013.10.001
Lexis, CP, Wieringa, WG, Hiemstra, B, et al. Chronic metformin treatment is associated with reduced myocardial infarct size in diabetic patients with STsegment elevation myocardial infarction. Cardiovasc Drugs Ther 2014;28 (2):163-171. https://doi.org/10.1007/s10557-013-6504-7
Mellbin, LG, Malmberg, K, Norhammar, A, et al. The impact of glucose lowering treatment on longterm prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. Eur Heart J 2008;29 (2):166-176. https://doi.org/10.1093/eurheartj/ehm518
Minuzzo, L, Santos, ES, Timerman, A. Association between angiotensinconverting enzyme inhibitors and troponin in acute coronary syndrome. Arq Bras Cardiol 2014;103 (6):513- 520. https://doi.org/10.5935/abc.20140155
Singh, SM, Goodman, SG, Yan, RT, et al. Relation between previous angiotensin-converting enzyme inhibitor use and in-hospital outcomes in acute coronary syndromes. Am J Cardiol 2012;109 (3):332-336. https://doi.org/10.1016/j.amjcard.2011.09.018
Kennon, S, Barakat, K, Hitman, GA, et al. Angiotensin-converting enzyme inhibition is associated with reduced troponin release in non-ST-elevation acute coronary syndromes. J Am Coll Cardiol 2001;38 (3):724-728. https://doi.org/10.1016/S0735-1097(01)01426-7
Alkuraishy, HM, Al-Gareeb, AI. New Insights into the Role of Metformin Effects on Serum Omentin1 Levels in Acute Myocardial Infarction: Cross-Sectional Study. Emerg Med Int 2015;2015 (10):283021. https://doi.org/10.1155/2015/283021
Nazer, RI, Abalhassan, MF, Alburikan, KA. Liver enzyme trends in patients taking uninterrupted metformin before and after coronary surgery. Cardiovasc Diagn Ther 2018;8 (4):469- 479. https://doi.org/10.21037/cdt.2018.05.04
Wu, CC, Hsu, WD, Islam, MM, et al. An artificial intelligence approach to early predict non-ST-elevation myocardial infarction patients with chest pain. Comput Methods Programs Biomed 2019;173 109-117. https://doi.org/10.1016/j.cmpb.2019.01.013
Kumar, A, Cannon, CP. Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc 2009;84 (10):917-938.https://doi.org/10.4065/84.10.917
Santos, ES, Baltar, VT, Pereira, MP, et al. Comparison between cardiac troponin I and CK-MB mass in acute coronary syndrome without st elevation. Arq Bras Cardiol 2011;96 (3):179-187. https://doi.org/10.1590/S0066-782X2011005000016
Chang, WC, Boersma, E, Granger, CB, et al. Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT. Am Heart J 2004;148 (1):62-71. https://doi.org/10.1016/j.ahj.2003.05.004
